Uterine cervix carcinoma in situ

MONDO:0042487

Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003

Also known as: CIN 3 aJCC v6, CIN grade 3 aJCC v6, FIGO stage 0 carcinoma of cervix, FIGO stage 0 carcinoma of cervix uteri, FIGO stage 0 carcinoma of the cervix, FIGO stage 0 carcinoma of the cervix uteri, FIGO stage 0 carcinoma of the uterine cervix, FIGO stage 0 carcinoma of uterine cervix

2869 clinical trials for this condition and its sub-types, 15 tagged with Uterine cervix carcinoma in situ itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Cervical carcinoma (317) ↑ Uterus carcinoma in situ (16)

Including sub-types (2869) Tagged with Uterine cervix carcinoma in situ (15)

Trials to join now! 5 Not yet recruiting 4 Not yet finished but already full! 3 Completed 2 Terminated 1

CRISPR zaps HPV in cervical lesions: first human test begins

Disease control Stopped early

This early study tests a new CRISPR gene therapy (BD114) in 12 women with high-grade cervical lesions caused by HPV-16. The therapy is injected directly into the lesion to disable the virus's cancer-causing genes. The main goals are to check safety and see if the lesions clear up…

Early phase 1 • Sponsor: Shanghai BDgene Co., Ltd. • Aim: Disease control

Last updated Sep 06, 2026 00:00 UTC

Uterine cervix carcinoma in situ

Where it sits in the disease tree

CRISPR zaps HPV in cervical lesions: first human test begins